Phosphate is a vascular toxin (Q38060627)

28 August 2017

1 reference

title

Phosphate is a vascular toxin (English)

1 reference

28 August 2017

1

1 reference

28 August 2017

17 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

28

1 reference

28 August 2017

583-593

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-012-2347-x

28 August 2017

0 references

cites work

Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

"Phosphatonins" and the regulation of phosphorus homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Progression of coronary calcification in pediatric chronic kidney disease stage 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Phosphorus is associated with coronary artery disease in patients with preserved renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Phosphate binders in CKD: chalking out the differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

The bone and mineral disorder of children undergoing chronic peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Association between clinical risk factors and progression of chronic kidney disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Increased arterial stiffness in young adults with end-stage renal disease since childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Carotid intima-media thickness in children with CKD: results from the CKiD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

A predictive model for progression of chronic kidney disease to kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Determinants of progressive vascular calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Effects of phosphate binders in moderate CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

The vascular biology of calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Vascular calcification: in vitro evidence for the role of inorganic phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Overview of the FGF23-Klotho axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Klotho deficiency causes vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Increased arterial stiffness in children on haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Long-Term Survival of Children with End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2347-X

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

21 January 2018

1 reference

12 December 2020

Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease

1 reference

12 December 2020

Carotid artery thickness in children and young adults with end stage renal disease

1 reference

12 December 2020

Can dialysis modality influence cardiovascular outcome?

1 reference

12 December 2020

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

1 reference

12 December 2020

Mineral Metabolism and Vascular Damage in Children on Dialysis

1 reference

12 December 2020

Coronary artery calcifications in children with end-stage renal disease

1 reference

12 December 2020

Cardiovascular mortality in children and young adults with end-stage kidney disease

1 reference

12 December 2020

Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis

1 reference

12 December 2020

Changes in left ventricular mass in children and adolescents during chronic dialysis

1 reference

12 December 2020

Left ventricular mass and systolic performance in pediatric patients with chronic renal failure

1 reference

12 December 2020

Coronary artery calcifications in children and young adults treated with renal replacement therapy

1 reference

12 December 2020

Aortic pulse wave velocity index and mortality in end-stage renal disease

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study

1 reference

12 December 2020

Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients

1 reference

12 December 2020

Coronary artery calcification in patients with CRF not undergoing dialysis

1 reference

12 December 2020

Intima media thickness in children undergoing dialysis

1 reference

12 December 2020

10.1007/S00467-012-2347-X

Identifiers

DOI

1 reference

PubMed ID

23161206

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23161206